These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Renal and hemodynamic effects of isradipine in essential hypertension. Persson B; Andersson OK; Wysocki M; Hedner T; Aurell M Am J Med; 1989 Apr; 86(4A):60-4. PubMed ID: 2523657 [TBL] [Abstract][Full Text] [Related]
4. Effects of the new calcium entry blocker isradipine (PN 200-110) in essential hypertension. Staessen J; Lijnen P; Fagard R; Hespel P; Tan WP; Devos P; Amery A J Cardiovasc Pharmacol; 1989 Feb; 13(2):271-6. PubMed ID: 2468957 [TBL] [Abstract][Full Text] [Related]
5. Antihypertensive activity of isradipine in humans: a new dihydropyridine calcium channel antagonist. Nelson EB; Pool JL; Taylor AA Clin Pharmacol Ther; 1986 Dec; 40(6):694-7. PubMed ID: 2946507 [TBL] [Abstract][Full Text] [Related]
6. Evaluation of isradipine (PN 200-110) in mild to moderate hypertension. Winer N; Thys-Jacobs S; Kumar R; Davidson WD; Grayson M; Harris C; Walker D; Itskovitz H; Gonasun L Clin Pharmacol Ther; 1987 Oct; 42(4):442-8. PubMed ID: 2959426 [TBL] [Abstract][Full Text] [Related]
7. Central hemodynamics and brachial artery compliance during therapy with isradipine, a new calcium antagonist. Andersson OK; Persson B; Widgren BR; Wysocki M J Cardiovasc Pharmacol; 1990; 15 Suppl 1():S87-9. PubMed ID: 1695312 [TBL] [Abstract][Full Text] [Related]
8. Efficacy and tolerability of the new calcium antagonist isradipine in essential hypertension. Kirch W; Burger KJ; Weidinger G; Welzel D J Cardiovasc Pharmacol; 1990; 15 Suppl 1():S55-9. PubMed ID: 1695304 [TBL] [Abstract][Full Text] [Related]
9. Effects of long-term administration of isradipine on renal hemodynamics and sodium metabolism. Francischetti EA; Barroso I; da Silva A; Fagundes VG J Cardiovasc Pharmacol; 1992; 19 Suppl 3():S90-2. PubMed ID: 1376847 [TBL] [Abstract][Full Text] [Related]
10. Treatment of essential hypertension with PN 200-110 (isradipine). Hamilton BP Am J Cardiol; 1987 Jan; 59(3):141B-145B. PubMed ID: 2949585 [TBL] [Abstract][Full Text] [Related]
11. Blood pressure control and haemodynamic adaptation with the dihydropyridine calcium antagonist isradipine: a controlled study in middle-aged hypertensive men. Andersson OK; Persson B; Hedner T; Aurell M; Wysocki M J Hypertens; 1989 Jun; 7(6):465-9. PubMed ID: 2528578 [TBL] [Abstract][Full Text] [Related]
12. Cardiovascular and renal effects of single administration of three different doses of isradipine in hypertensive patients. Dose-response curves of the different effects. Rupoli L; Fruscio M; Gradnik R; Chianca R; Leonetti G; Zanchetti A Am J Med; 1989 Apr; 86(4A):65-6. PubMed ID: 2523658 [TBL] [Abstract][Full Text] [Related]
13. Effects of isradipine on hypertension and renal hemodynamics. Siamopoulos KC; Elisaf M; Dardamanis M; Sferopoulos G; Pappas M J Cardiovasc Pharmacol; 1992; 19 Suppl 3():S87-9. PubMed ID: 1376846 [TBL] [Abstract][Full Text] [Related]
14. Calcium antagonists as first-line antihypertensive agents: a placebo-controlled, comparative trial of isradipine and nifedipine. Welzel D; Burger KJ; Weidinger G J Cardiovasc Pharmacol; 1990; 15 Suppl 1():S70-4. PubMed ID: 1695308 [TBL] [Abstract][Full Text] [Related]
15. Long-term effects of isradipine on blood pressure and renal function. Pedersen OL; Krusell LR; Sihm I; Jespersen LT; Thomsen K Am J Med; 1989 Apr; 86(4A):15-8. PubMed ID: 2523650 [TBL] [Abstract][Full Text] [Related]
16. The effects of isradipine and spirapril as monotherapy and combined therapy on blood pressure, renal hemodynamics, natriuresis, and urinary kallikrein in hypertensive nephropathy. Maccariello ER; Genelhu de Abreu Fagundes V; Francischetti EA Am J Hypertens; 1997 May; 10(5 Pt 1):541-5. PubMed ID: 9160765 [TBL] [Abstract][Full Text] [Related]
17. A multicenter evaluation of the safety and efficacy of isradipine and atenolol in the treatment of hypertension. Isradipine in Hypertension Study Group. Am J Med; 1989 Apr; 86(4A):119-23. PubMed ID: 2523646 [TBL] [Abstract][Full Text] [Related]
18. Renal effects of the new calcium channel blocking drug isradipine. Krämer BK; Häussler M; Ress KM; Müller GA; Burger KJ; Risler T Eur J Clin Pharmacol; 1990; 39(4):333-5. PubMed ID: 2150190 [TBL] [Abstract][Full Text] [Related]
19. The long-term effect of isradipine in pindolol-treated patients. Dahlöf B; Andrén L; Eggertsen R; Jern S; Svensson A; Hansson L J Hypertens Suppl; 1987 Dec; 5(5):S567-70. PubMed ID: 2965231 [TBL] [Abstract][Full Text] [Related]
20. A randomized comparison of isradipine slow release given once daily with isradipine twice daily on 24 hour blood pressure in hypertensive patients. Christensen HR; Kampmann JP; Simonsen K J Hum Hypertens; 1991 Apr; 5(2):121-7. PubMed ID: 1830108 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]